These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 17292473

  • 21. Mechanism and clinical significance of prostaglandin-induced iris pigmentation.
    Stjernschantz JW, Albert DM, Hu DN, Drago F, Wistrand PJ.
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S162-75. PubMed ID: 12204714
    [Abstract] [Full Text] [Related]

  • 22. A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost.
    Chiba T, Kashiwagi K, Ishijima K, Furuichi M, Kogure S, Abe K, Chiba N, Tsukahara S.
    Jpn J Ophthalmol; 2004 Aug; 48(2):141-7. PubMed ID: 15060793
    [Abstract] [Full Text] [Related]

  • 23. Assessment of chamber angle pigmentation during longterm latanoprost treatment for open-angle glaucoma.
    Nakamura Y, Nakamura Y, Morine-Shinjo S, Sakai H, Sawaguchi S.
    Acta Ophthalmol Scand; 2004 Apr; 82(2):158-60. PubMed ID: 15043533
    [Abstract] [Full Text] [Related]

  • 24. Evidence of early change in iris color with latanoprost use.
    Pappas RM, Pusin S, Higginbotham EJ.
    Arch Ophthalmol; 1998 Aug; 116(8):1115-6. PubMed ID: 9715697
    [No Abstract] [Full Text] [Related]

  • 25. Effect of age on the development of a latanoprost-induced increase in iris pigmentation.
    Arranz-Marquez E, Teus MA.
    Ophthalmology; 2007 Jul; 114(7):1255-8. PubMed ID: 17306877
    [Abstract] [Full Text] [Related]

  • 26. A 5-year, multicenter, open-label, safety study of adjunctive latanoprost therapy for glaucoma.
    Alm A, Schoenfelder J, McDermott J.
    Arch Ophthalmol; 2004 Jul; 122(7):957-65. PubMed ID: 15249358
    [Abstract] [Full Text] [Related]

  • 27. Latanoprost stimulates eumelanogenesis in iridial melanocytes of cynomolgus monkeys.
    Prota G, Vincensi MR, Napolitano A, Selen G, Stjernschantz J.
    Pigment Cell Res; 2000 Jun; 13(3):147-50. PubMed ID: 10885672
    [Abstract] [Full Text] [Related]

  • 28. Histological effects in the iris after 3 months of latanoprost therapy: the Mainz 1 study.
    Pfeiffer N, Grierson I, Goldsmith H, Hochgesand D, Winkgen-Böhres A, Appleton P.
    Arch Ophthalmol; 2001 Feb; 119(2):191-6. PubMed ID: 11176979
    [Abstract] [Full Text] [Related]

  • 29. The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye color.
    Wistrand PJ, Stjernschantz J, Olsson K.
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S129-38. PubMed ID: 9154289
    [Abstract] [Full Text] [Related]

  • 30. Characterization of melanins in human irides and cultured uveal melanocytes from eyes of different colors.
    Prota G, Hu DN, Vincensi MR, McCormick SA, Napolitano A.
    Exp Eye Res; 1998 Sep; 67(3):293-9. PubMed ID: 9778410
    [Abstract] [Full Text] [Related]

  • 31. Visualization of changes of the iris configuration after peripheral laser iridotomy in primary melanin dispersion syndrome using optical coherence tomography.
    Laemmer R, Mardin CY, Juenemann AG.
    J Glaucoma; 2008 Sep; 17(7):569-70. PubMed ID: 18854735
    [Abstract] [Full Text] [Related]

  • 32. The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy.
    Sharpe ED, Reynolds AC, Skuta GL, Jenkins JN, Stewart WC.
    Curr Eye Res; 2007 Dec; 32(12):1037-43. PubMed ID: 18085467
    [Abstract] [Full Text] [Related]

  • 33. Age-related melanogenesis in the eye of mice, studied by microautoradiography of 3H-methimazole, a specific marker of melanin synthesis.
    Lindquist NG, Larsson BS, Stjernschantz J, Sjöquist B.
    Exp Eye Res; 1998 Sep; 67(3):259-64. PubMed ID: 9778406
    [Abstract] [Full Text] [Related]

  • 34. Side effects associated with prostaglandin analog therapy.
    Alm A, Grierson I, Shields MB.
    Surv Ophthalmol; 2008 Nov; 53 Suppl1():S93-105. PubMed ID: 19038628
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Increased iris pigment in a child due to latanoprost.
    Brown SM.
    Arch Ophthalmol; 1998 Dec; 116(12):1683-4. PubMed ID: 9869807
    [No Abstract] [Full Text] [Related]

  • 40. Prostaglandin analogues in the anterior eye: their pressure lowering action and side effects.
    Cracknell KP, Grierson I.
    Exp Eye Res; 2009 Apr; 88(4):786-91. PubMed ID: 18930047
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.